DHR Health Institute for Research and Development — Edinburg, Texas

Public research footprint of DHR Health Institute for Research and Development, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · COVID-19 · Nonalcoholic Steatohepatitis · Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT07165028 — A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated… (Recruiting)
NCT05008848 — Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at DHR Health Institute for Research and Development?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.